Back
Day Range
$56.30
$58.64
52-Week Range
$9.57
$76.76
Volume
1,674,215
50D / 200D Avg
$63.61
/
$41.41
Prev Close
$56.33
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4865.5 | 0.4 |
| P/B | 17.0 | 2.9 |
| ROE % | -0.5 | 3.8 |
| Net Margin % | -0.2 | 3.9 |
| Rev Growth 5Y % | 56.5 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 56.50% annually over 5 years — strong growth
Generating 156.89M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 23201.65%
Capital efficient — spends only 2.73% of revenue on capex
Interest coverage of 1.10× — tight debt servicing
Growth
Revenue Growth (5Y)
56.50%
Revenue (1Y)23258.15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-0.50%
ROIC8.86%
Net Margin-0.20%
Op. Margin11.86%
Safety
Debt / Equity
0.79
Current Ratio4.86
Interest Coverage1.10
Valuation
P/E Ratio
-4865.50
P/B Ratio17.03
EV/EBITDA82.11
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23258.15% | Revenue Growth (3Y) | 85.62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 56.50% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 829.45M | Net Income (TTM) | -1.63M |
| ROE | -0.50% | ROA | -0.12% |
| Gross Margin | 97.12% | Operating Margin | 11.86% |
| Net Margin | -0.20% | Free Cash Flow (TTM) | 156.89M |
| ROIC | 8.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.79 | Current Ratio | 4.86 |
| Interest Coverage | 1.10 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4865.50 | P/B Ratio | 17.03 |
| P/S Ratio | 9.57 | PEG Ratio | 28.35 |
| EV/EBITDA | 82.11 | Dividend Yield | 0.00% |
| Market Cap | 7.94B | Enterprise Value | 8.08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 829.45M | 3.55M | 240.74M | 243.23M | 138.29M |
| Net Income | -1.63M | -599.49M | -205.28M | -176.06M | -140.85M |
| EPS (Diluted) | -0.01 | -5.00 | -1.92 | -1.67 | -1.36 |
| Gross Profit | 805.52M | 3.55M | 240.74M | 243.23M | 138.29M |
| Operating Income | 98.35M | -601.08M | -205.00M | -178.51M | -149.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.39B | 1.14B | 765.55M | 691.94M | 710.15M |
| Total Liabilities | 881.88M | 948.74M | 478.39M | 273.60M | 301.33M |
| Shareholders' Equity | 466.05M | 185.44M | 271.34M | 398.52M | 408.82M |
| Total Debt | 366.28M | 851.91M | 383.50M | 81.58M | 25.55M |
| Cash & Equivalents | 226.55M | 102.69M | 110.89M | 108.01M | 184.43M |
| Current Assets | 950.64M | 695.47M | 419.52M | 405.30M | 384.60M |
| Current Liabilities | 195.49M | 103.17M | 105.46M | 138.85M | 146.54M |